Multiple Sclerosis Treatment Market 2020 – Key Stakeholders, Subcomponent Manufacturers, Industry Association 2025 - Jewish Life News

The study on the “Multiple Sclerosis Treatment Market” by Brand Essence Market Research is a compilation of systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also offers a precise analysis of the key challenges and growth prospects awaiting key players of the Multiple Sclerosis Treatment market, including a concise summary of their corporate strategies and competitive setting.

In 2018, the Global Multiple Sclerosis Treatment Market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

Download Premium Sample of the Report: https://industrystatsreport.com/Request/Sample?ResearchPostId=12654&RequestType=Sample

The Detailed Market intelligence report on the Global Multiple Sclerosis Treatment Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Multiple Sclerosis Treatment Market place for the forecast 2020– 2025.

Scope Of The Report:

Continue reading
  27 Hits

Copyright

© news.google.com

27 Hits

Severe COVID-19 Outcomes for MS Patients Linked to Several Factors - MD Magazine

This article, "Severe COVID-19 in Multiple Sclerosis Linked to Disability Status, Age, Obesity," was originally published in NeurologyLive.

The outcomes for patients with multiple sclerosis (MS) infected by the coronavirus disease 2019 (COVID-19) might be more severe, according to new research.

In a recent attempt to understand the risk factors involved for patients with MS to possibly develop a severe form of the novel COVID-19 infection, results suggest that neurological disability, age, and obesity were all associated with severe infection.

No link was observed between exposure to disease-modifying therapies (DMTs) and COVID-19 severity.

Conducted by Céline Louapre, MD, PhD, of the Clinical Investigation Center, L'Institut du Cerveau et de la Moelle Épinière, and colleagues, the cohort study included 347 patients with MS. Infection severity was assessed on a 7-point ordinal scale ranging from 1—denoting no hospitalization with no limitations on activities—to 7—denoting death.

There was a cutoff at 3 on the scale, which was defined as hospitalized and not requiring supplemental oxygen.

Continue reading
  17 Hits

Copyright

© news.google.com

17 Hits

Sandra Beaning - Obituary - Legacy.com

Sandra K. Beaning

Indianapolis - Sandra K. Beaning, 85, Indianapolis, passed away June 25, 2020. Sandy was born on December 21, 1934 to Benjamin and Helen Jordan, living in Indianapolis all her life, being survived by her sister Patricia Miller, Dunedin, Florida; niece Annette Lawrence, Dunedin, Florida; Amy Craft and family, Wesley Chapel Florida; plus nephew David Miller and his family in Dayton, Ohio.

She attended Shortridge High School, achieving and AB Degree from Hanover College, Madison, Indiana, with a Masters Degree from Butler University, Indianapolis. For her entire career, Sandy taught in the Indianapolis Public Schools, Grade Six, on East Washington Street for 37 years until retirement.

Sandy fell in love with Robert "Bob" Beaning and married him in June 1959. They took summer vacations to Grand Teton Mountains and some Western States.

Narrative continues below by long-time friend, Joseph V. Goeller:

I met Sandy as her husband, Bob, and I both worked for Allstate Insurance and were 10-Speed bike enthusiasts. After we would ride over rural roads and elsewhere in Central Indiana, Sandy would cook delicious breakfasts for the three of us Sunday mornings, eating on the Chateau de Ville patio. On one year, he and I even rode a 100-mile roundtrip along Interstate 70 to Knightstown and back.

Continue reading
  17 Hits

Copyright

© news.google.com

17 Hits

2025 Projections: Multiple Sclerosis Industry Market Report by Type, Application and Regional Outlook - AlgosOnline

MarketStudyReport.com Adds New Report about Global Multiple Sclerosis Industry Market to its database. This research covers the market landscape and its growth prospects over the coming years.

The research study on the Multiple Sclerosis Industry market is a detailed analysis of this industry vertical and includes substantial information – like the present status of the market over the projected timeline. The basic development trends that the Multiple Sclerosis Industry market is characterized by over the forecast timeframe is provided in the report, in tandem with the vital pointers such as geographical industry layout characteristics as well as the various industry policies.

Request a sample Report of Multiple Sclerosis Industry Market at: https://www.marketstudyreport.com/request-a-sample/2764238?utm_source=algosonline.com&utm_medium=TS

The Multiple Sclerosis Industry market research report is also inclusive of a plethora of pros and cons of the enterprise products. Pointers such as the influence of the present market scenario on investors have been provided. Also, the study elaborates on the enterprise competition trends in conjunction with a detailed scientific analysis on downstream buyers as well as the raw material.

Unveiling a gist of the Multiple Sclerosis Industry market competitive scope:

Continue reading
  30 Hits

Copyright

© news.google.com

30 Hits

Why these players decided not to play this season - Chron

Why these players decided not to play this season

With the NBA and Major League Baseball planning on playing at the end of the month, some players have decided to sit out the season.

Deciding to return to work during the pandemic is a personal decision for anyone, but some of the players have shared their reasoning for opting out of their sport during this time.

The Lakers' Avery Bradley, for instance, has a 6-year-old child with a history of struggling to recover from respiratory illnesses, meaning that child likely would not be allowed to join Bradley with his family in the Orlando bubble. Nationals infielder Ryan Zimmerman has four children, including a newborn, and a mother who has Multiple Sclerosis.

Continue reading
  26 Hits

Copyright

© news.google.com

26 Hits

Experts Confident Biden’s COVID-19 Response Could Speed Recovery

Share on PinterestMedical experts say they believe Biden’s plan to address COVID-19 would emphasize a better future for how to handle the continued threat of the outbreak. Getty Images
Democratic presidential candidate Joe Biden has outlined a range of proposals for crafting a better national response to the COVID-19 pandemic.Medical experts say a lack of testing and supplies early on in the pandemic here in the U.S. hampered our response.However, they are encouraged by Biden’s plan since it calls for listening to experts in the field and relying on a task force to monitor and bring about more serious COVID-19 testing procedures.Nevertheless, they emphasize the need for additional changes to our healthcare system to effectively respond to a crisis like this in the future.

It’s now officially summer and increasingly more states are reopening their economies after a winter and spring where the United States effectively shut down during the first wave of the COVID-19 pandemic.

At the same time that summer temperatures rise and the nation at large grapples with how best to handle the coronavirus outbreak and protect against surges in new cases, a divisive general election season is heating up.

President Donald Trump and presumptive Democratic Party nominee former Vice President Joe Biden are running against each other during a time when concerns over people’s individual health, the nation’s healthcare system, and state and federal response to COVID-19 all take center stage in both political and public health debates.

This spring, as criticism continued to build up over the federal government’s response to COVID-19 testing and tracing nationwide, the Biden campaign released its own coronavirus outbreak response plan. In a blog post published on Medium, the campaign’s public health advisory committee laid out an extensive COVID-19 testing plan.

In the post, the campaign asserts that reopening and strengthening the U.S. economy and protecting the public health of its citizens shouldn’t be mutually exclusive. They outline a range of proposals for crafting a better national COVID-19 response, from increased supply and access to personal protective equipment (PPE) to more rigorous testing and tracing for the coronavirus.

Continue reading
  32 Hits

Copyright

© healthline.com

32 Hits

Coronavirus Outbreak: Daily Updates

The outbreak, initially identified in China, is continuing to grow.The disease is called COVID-19. It’s caused by an infection with the new coronavirus, SARS-CoV-2, which is one of multiple coronaviruses that can be transmitted to humans.Other examples of coronaviruses include SARS, MERS, and even the common cold.
Globally, there have been more than 10.3 million confirmed cases and more than 500,000 associated deaths, according to Johns Hopkins.The United States currently has the highest reported number of confirmed cases with over 2.6 million. However, due to a lack of testing, the number of actual cases may be far higher. More than 126,000 people in the United States have died from the disease and more than 30,000 are currently being hospitalized.

Healthline will update this page every weekday. For more information about the virus, go here.

Leaders of the European Union have announced that most travelers from the United States will be barred from entering when countries reopen their borders on Wednesday.

The European leaders said they’re taking the action because the spread of COVID-19 is still too prevalent in the United States.

They also said the list of countries from which travelers can arrive will be reviewed every 2 weeks and could be revised.

More time spent indoors to escape summer’s heat may increase risk of COVID-19, according to Edward Nardell, a professor of medicine and global health and social medicine at Harvard Medical School in Massachusetts.

Continue reading
  40 Hits

Copyright

© healthline.com

40 Hits

How Barbers Are Stepping Up for Black Men and Mental Health

Share on PinterestThe Confess Project, a nonprofit organization, is working to change conversations about mental health in communities of color by utilizing barbers to connect with Black men. Image via The Confess Project
The Confess Project is a nonprofit organization that utilizes barbers across the country to connect with men of color and raise awareness about mental health.Through a 12-month curriculum, barbers get trained on active listening, validating clients’ emotions and concerns, and how to use positive language to combat stigma around mental health. They also learn about mental health resources in their area to which they can direct clients.Family support, social support networks, and education are primary reasons people go to and remain in mental health services when they need them.

Lorenzo P. Lewis was born while his parents were incarcerated. At birth, his aunt was declared his legal guardian. When he was 10 years old, his father died from substance use.

“My being born in prison was a symptom of generational trauma. Across both sides of my families, I have several family members who were incarcerated and who had substance abuse. I believe trauma evolves over generations and doesn’t just happen to one person,” Lewis told Healthline.

While his aunt was an involved caregiver and provided the basic needs of food and shelter, he said the emotional distress he experienced from being disconnected from his parents and siblings manifested into trauma.

As a child and teenager, Lewis struggled with educational, behavioral, emotional, and physical distress, including obesity. He also experienced anger, irritability, anxiety, and depression, but wasn’t diagnosed with major depression until his 30s.

“I also experienced racism in schools early on around the time my dad died. [Shortly after], I had to spend 3 months in a behavioral health facility, which was a big shift in how I view the world,” said Lewis.

Continue reading
  8 Hits

Copyright

© healthline.com

8 Hits

Who Is Most At-Risk for Severe COVID-19?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers and for a little amusement, here is a 10-question quiz based on the news of the week. Topics include COVID-19 risk factors, future pandemic preparation, and effects on kids from parents' mental illness. After taking the quiz, scroll down in your browser window to find the correct answers and explanations, as well as links to the original articles.

  25 Hits

Copyright

© MedPage Today Neurology

25 Hits

RELX Presents Infinity

Image: RELX

RELX Technology has launched two new e-cigarettes: Infinity and Essential.

Using independently developed “super smooth performance” technology, both products offer full flavor and “velvety smooth” puffs, according to RELX.

“The Infinity demonstrates our focus on relentless technological innovation,” said RELX CEO Kate Wang. “I’m proud of the entire RELX global team for creating a beautifully designed device with superior technology, and with a dedication to innovation that RELX is now globally known for.”

To ensure leak resistance and high quality, RELX’s engineers tested more than 12,000 Infinity pods. The company has submitted patent applications for more than 50 innovations used in the device. In March 2020, the Infinity was awarded the Red Dot Award: Product Design 2020.

(Originally posted by admin)
  5 Hits
Tags:

Copyright

© vaporvoicemagazine.com

5 Hits

Thailand Asked to Consider Science in Vapor Regulation

Scenes like this are rare in Thailand. This vaper in Koh Samui, Thailand could face fines or even jail. (Timothy S. Donahue)

A consumer advocacy group wants the government of Thailand to consider science as basis for ending e-cigarette ban. The group cites Hong Kong’s use of scientific studies as the basis for ending the ban on smoke-free nicotine, including vapor, heat-not-burn tobacco products (HnB) and snus.

Asa Ace Saligupta, who runs consumer group ENDS Cigarette Smoke Thailand, said the Hong Kong Legislative Council (Legco) decided to suspend the discussions on the proposed ban on vaping products, after some members of Legco’s Bills Committee on Smoking cited scientific studies showing that e-cigarettes, HnB and the likes have much lower levels of toxicants compared to combustible cigarettes, according to a release on pressat.co.uk.

He noted that after nine meetings, including three public hearings, the committee which was established in March 2019 decided to end the discussions on the vaping ban on June 2, 2020. The members of the committee also expressed concern that an outright ban would create more illegal channels and that the products could end up in the hands of underage users.

“The Hong Kong experience sets forward a good example of listening to opinions and engaging all parties involved, including the public sector—something that the policymakers in Thailand have avoided so far,” Saligupta said.

Saligupta said his group will petition the Thai government to also set up a committee to study e-cigarettes and find suitable control channels that will enable adult Thai cigarette smokers to find safer alternatives.

Continue reading
  33 Hits
Tags:

Copyright

© vaporvoicemagazine.com

33 Hits

FDA Will Not Request Extension to Sept. 9 PMTA Deadline

Credit: Succo

The U.S. Food & Drug Administration (FDA) does not intend to delay the current Sept. 9, 2020 deadline for the vapor industry to submit applications for marketing authorization before a hearing is scheduled for the plaintiffs in the case.

In a status report filed Wednesday to the U.S. District Court for the District of Columbia, the regulatory agency told the court that it does “not currently plan to seek an extension of the September 9, 2020 premarket application deadline.”

Any extension requested by the plaintiffs could be complicated because the request would have to be approved by the Maryland-based federal court that forced the agency to move the deadline to May 12, 2020 due to a separate lawsuit.

The FDA has already delayed the PMTA deadline due to the Covid-19 pandemic. The deadline was previously scheduled for May 12, 2020 but was moved to Sept. 9. According to the FDA’s status report, the plaintiffs in the case are expected to file a status report requesting their preferred argument date for a further extension.

(Originally posted by admin)
  50 Hits
Tags:

Copyright

© vaporvoicemagazine.com

50 Hits

L.A. Moving to Make Changes to Its Legal Marijuana Market

Los Angeles City Council voted unanimously Wednesday to make numerous changes to its once-flourishing marijuana market. The legislative body gave its initial approval to expand licensing and get more assistance to operators who endured the consequences of the nation’s war on drugs.

Broad legal sales kicked off in California in 2018, and at that time Los Angeles was expected to quickly establish itself as a world-leading cannabis economy, according to an article from the Associated Press. “But that never happened. Instead, robust illegal sales continue to outpace the up-and-down legal market, while businesses complain that hefty taxes and a cumbersome bureaucracy have slowed, rather than encouraged, growth,” the article states.

The new revisions are designed to provide a jump in licenses for so-called “social-equity” applicants. These include individuals, many of color, who were arrested or convicted of a marijuana-related offense, and lower-income residents who live, or have lived, in neighborhoods marked by high marijuana arrest rates.

Only applicants meeting those criteria would be eligible for new retail and delivery licenses through 2025.

The council also seeks to help businesses wanting licenses to quickly get temporary approval to begin operating once certain benchmarks are met. The rules would permit businesses to relocate while being licensed and streamline the application process, according to the article.

Continue reading
  78 Hits
Tags:

Copyright

© vaporvoicemagazine.com

78 Hits

Arizona Bar Bans Vapor Over Covid-19 Concerns

Photo: Vchalup | Dreamstime.com

A bar in Chandler, Arizona is asking customers to vape outside because they worry vape clouds could spread Covid-19. The bar, Tom Ryan’s, recently took to their social media pages to inform customers that vaping was no longer allowed indoors.

Bar manager Paige Lokkessmoe said that after seeing a spike in COVID-19 cases it wasn’t sitting well with them to allow people to keep vaping inside, according to an article on azfamily.com. Numerous public health experts, including the U.S. Food and Drug Administration and the U.S. Centers for disease Control and Prevention have said there is no evidence e-cigarette vapor spreads Covid.19

“We decided to stop allowing vaping in the bar because we were, kind of, just looking at the vaping smoke and seeing it settle everywhere around us. And the concern is the ice [and] the bottles that have pour spouts on them,” Lokkessmoe said.

According to Dan Quan, a toxicologist from the University of Arizona College of Medicine, the droplets that people produce when they sneeze or cough are the same as when they exhale, say, a cloud of smoke.

“Let’s say I take a deep breathe in and I exhale forcibly, I mean, there are still some droplets that form– and that’s why we suggest everyone wear masks because it does cut down on the amount of droplets dispersed in the air,” Quan said, adding that if you’re going to vape, take it outside because the fresh air will help dilute the droplets. Vaping and smoking will still be allowed on the patio at Tom Ryan’s.

Original author: admin
  62 Hits
Tags:

Copyright

© vaporvoicemagazine.com

62 Hits

Hookworm trial offers new hope to MS patients

Parasitic worms could offer a new treatment hope for patients suffering from the autoimmune disease Multiple Sclerosis, according to experts from the University of Nottingham.

The findings of the research, published in the journal JAMA Neurology, show that infecting MS patients with a safe dose of the hookworm parasite Necator americanus induces immunoregulatory responses and boosts the number of cells which help keep the immune system under control.

The research was led by Cris Constantinescu, Professor of Neurology in the University's School of Clinical Sciences and a leading MS expert, and David Idris Pritchard, Professor of Parasite Immunology in the University's School of Pharmacy, who has spent decades studying the biology of the hookworm. The study was funded by the Multiple Sclerosis Society.

MS is a condition that can affect the brain and spinal cord, causing a wide range of potential symptoms, including problems with vision, arm or leg movement, sensation or balance. Whilst treatments are available, there is currently no cure.

The study aimed to show that the presence of hookworms in the body switches off the mechanism by which the body's immune system becomes overactive -- the main cause of MS -- reducing both the severity of symptoms and the number of relapses experienced by the patients.

Continue reading
  32 Hits

Copyright

© ScienceDaily

32 Hits

Experts evaluate options for treating cognitive deficits in multiple sclerosis

Experts evaluate options for treating cognitive deficits in multiple sclerosis

Reviewed by Emily Henderson, B.Sc.Jun 16 2020

Experts in cognitive research evaluated the status of available treatments as well as promising strategies for treating cognitive deficits in Multiple Sclerosis. The article, "Treatment and management of cognitive dysfunction in patients with Multiple Sclerosis", was published in Nature Reviews 2020 May 05. (doi: 10.1038/s41582-020-0355-1) The authors are John DeLuca, PhD, and Nancy Chiaravalloti, PhD, of Kessler Foundation, and Brian Sandroff, PhD, of the University of Alabama at Birmingham.

Cognitive dysfunction is a common, disabling symptom of Multiple Sclerosis, affecting two-thirds of patients. These individuals can have difficulties managing finances, performing household tasks, and functioning in the community and the workplace. Although the impact on daily life may be profound, the diagnosis and management of cognitive dysfunction in this population remains inadequate. The authors provided detailed analyses of different approaches to treatment, including cognitive rehabilitation, exercise training, and pharmacotherapy, and the important contributions of brain neuroimaging to advances in this field.

Over the past decade, research activity in cognitive rehabilitation has increased in the population with MS. There is greater emphasis on cognitive screening and assessment, and some standardized treatment protocols are available.

Evidence suggests that cognitive rehabilitation is effective in MS-related cognitive dysfunction, and may confer long-lasting effects. Access to cognitive rehabilitation therapy is likely to increase as remote options for delivery become more widely accepted, such as programs for home computers and telerehabilitation services."

Continue reading
  26 Hits

Copyright

© news-medical.net

26 Hits

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Reviewed by Emily Henderson, B.Sc.Jun 17 2020

Researchers at Kessler Foundation conducted a comprehensive review of pharmacologic agents used in the treatment of Multiple Sclerosis, seeking evidence for efficacy for the cognitive dysfunction experienced by more than half of affected individuals. The article, "Cognitive efficacy of pharmacologic treatments in Multiple Sclerosis: A systematic review," was published open access in CNS Drugs 2020 May 02. (doi: 10.1007/s40263-020-00734-4) The authors are Michelle H. Chen, PhD, Helen Genova, PhD, and John DeLuca, PhD, of Kessler Foundation. Yael Goverover, PhD, of New York University, is a visiting scientist at Kessler Foundation.

Researchers identified 87 articles, using the PubMed and PsycINFO databases and the 2017 American Academy of Neurology (AAN) criteria for therapeutic trials. Standardized effect sizes were calculated for comparison across trials.

Agents from the following therapeutic categories were represented: disease-modifying therapies (DMTs) (interferon B-1a, B1b, Glatiramer Acetate, Natalizumab, Fingolimod); Symptomatic therapies (dalfampridine; cognition enhancers: rivastigmine, Gingko biloba, donepezil; Stimulants: modafinil, armodafinil, methylphenidate, amphetamine sulfate, amantadine); and 'Other' therapies that were neither DMTs nor stimulants (eg, estrogen, methylprednisolone, simvastatin, human erythropoietin).

Review of the studies of DMTs failed to support effectiveness for treating cognitive deficits, with a majority of class III and IV evidence. "We found no class I evidence, and class II evidence was minimal to none," said Dr. Chen, postdoctoral fellow in the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.

Continue reading
  26 Hits

Copyright

© news-medical.net

26 Hits

Parasitic worms could offer new treatment hope for MS patients

Parasitic worms could offer new treatment hope for MS patients

Reviewed by Emily Henderson, B.Sc.Jun 18 2020

Parasitic worms could offer a new treatment hope for patients suffering from the autoimmune disease Multiple Sclerosis, according to experts from the University of Nottingham.

The findings of the research, published in the journal JAMA Neurology, show that infecting MS patients with a safe dose of the hookworm parasite Necator americanus induces immunoregulatory responses and boosts the number of cells which help keep the immune system under control.

The research was led by Cris Constantinescu, Professor of Neurology in the University's School of Clinical Sciences and a leading MS expert, and David Idris Pritchard, Professor of Parasite Immunology in the University's School of Pharmacy, who has spent decades studying the biology of the hookworm. The study was funded by the Multiple Sclerosis Society.

MS is a condition that can affect the brain and spinal cord, causing a wide range of potential symptoms, including problems with vision, arm or leg movement, sensation or balance. Whilst treatments are available, there is currently no cure.

Continue reading
  22 Hits

Copyright

© news-medical.net

22 Hits

U.K. to roll out the largest genetic study on chronic fatigue syndrome

U.K. to roll out the largest genetic study on chronic fatigue syndrome

By Angela Betsaida B. Laguipo, BSNJun 24 2020

Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.

Now, the United Kingdom is launching the first-ever genetic study on chronic fatigue syndrome, which affects 20 million people worldwide. In the U.K., it is believed that CFS affects about 250,000 people.

Image Credit: Smile Fight / Shutterstock

World's first genetic study

The genetic study, called Decode ME, aims to help provide a better understanding of the disease and find effective treatments. The ME/CFS Biomedical Partnership spearheads the study, in collaboration with scientists and patients who have ME/CFS.

Continue reading
  54 Hits

Copyright

© news-medical.net

54 Hits

Majority of people with MS use complementary and alternative medicine, survey finds

Majority of people with MS use complementary and alternative medicine, survey finds

Reviewed by Emily Henderson, B.Sc.Jun 25 2020

A new survey of more than 1,000 people with Multiple Sclerosis finds that an overwhelming majority use complementary and alternative medicine, with many using cannabis.

Researchers at Oregon Health & Science University conducted the survey of people in Oregon and Southwest Washington in 2018. The results were published recently in the journal Multiple Sclerosis and Related Disorders.

The survey found that patients are nine times more likely to talk with their neurologist about the use of alternative therapies than patients in a similar survey conducted in 2001, a sign of broader societal acceptance of treatments beyond conventional medications. In the years since the first survey, several conventional medications have become available to manage MS-related disease activity.

Even so, patients appear to be more inclined to use alternatives such as dietary supplements, despite limited evidence of their effectiveness.

Continue reading
  40 Hits

Copyright

© news-medical.net

40 Hits